tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Aschoff, 91 are a BUY (88.35%), 8 are a HOLD (7.77%), 4 are a SELL (3.88%).
Analyst Jonathan Aschoff, carries an average stock price target met ratio of 36.89% that have a potential upside of 30.03% achieved within 109 days.
Jonathan Aschoff’s has documented 186 price targets and ratings displayed on 36 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on APVO, Aptevo Therapeutics at 23-Sep-2024.
Analyst best performing recommendations are on PBLA (PANBELA THERAPEUTICS).
The best stock recommendation documented was for PBLA (PANBELA THERAPEUTICS) at 12/18/2023. The price target of $25 was fulfilled within 1 day with a profit of $4.8 (23.76%) receiving and performance score of 237.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$205
$22.5 (12.33%)
4 years 5 months 7 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 5 months 9 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 5 months 16 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy
$175
$-7.5 (-4.11%)
$165
4 years 8 months 8 days ago
(03-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold
$166
$-16.5 (-9.04%)
$175
4 years 8 months 8 days ago
(03-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
What Year was the first public recommendation made by Jonathan Aschoff?
